Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$288.23 - $331.73 $20.2 Million - $23.3 Million
70,174 Added 113.31%
132,106 $41.4 Million
Q1 2024

May 13, 2024

SELL
$247.84 - $340.0 $12.2 Million - $16.8 Million
-49,371 Reduced 44.36%
61,932 $20.8 Million
Q4 2023

Feb 14, 2024

BUY
$222.83 - $285.76 $24.8 Million - $31.8 Million
111,303 New
111,303 $31.5 Million
Q2 2023

Aug 14, 2023

BUY
$183.12 - $250.2 $11.1 Million - $15.2 Million
60,757 New
60,757 $15.2 Million
Q4 2022

Feb 14, 2023

BUY
$173.9 - $224.8 $668,645 - $864,356
3,845 New
3,845 $746,000
Q2 2022

Aug 15, 2022

BUY
$197.3 - $261.32 $15.5 Million - $20.5 Million
78,639 Added 1125.67%
85,625 $18.6 Million
Q1 2022

May 16, 2022

BUY
$216.09 - $296.03 $1.51 Million - $2.07 Million
6,986 New
6,986 $1.7 Million
Q4 2021

Feb 14, 2022

SELL
$258.11 - $309.7 $9.75 Million - $11.7 Million
-37,785 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$208.53 - $283.04 $7.62 Million - $10.3 Million
36,565 Added 2997.13%
37,785 $9.9 Million
Q2 2021

Aug 16, 2021

BUY
$194.07 - $232.2 $236,765 - $283,284
1,220 New
1,220 $252,000
Q2 2019

Aug 14, 2019

SELL
$129.99 - $153.97 $1.15 Million - $1.36 Million
-8,862 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$121.3 - $146.95 $1.07 Million - $1.3 Million
8,862 New
8,862 $1.21 Million
Q2 2018

Aug 14, 2018

SELL
$111.38 - $137.03 $1.11 Million - $1.37 Million
-10,001 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$103.82 - $123.9 $1.04 Million - $1.24 Million
10,001 New
10,001 $1.18 Million
Q4 2017

Feb 14, 2018

SELL
$111.14 - $123.05 $7.5 Million - $8.31 Million
-67,508 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$101.4 - $116.62 $6.85 Million - $7.87 Million
67,508
67,508 $7.69 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $16.6B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.